Canada Life
BEAM icon

Canada Life’s Beam Therapeutics BEAM Stock Holding History

Canada Life’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
30,081
+5,490
+22% +$166K ﹤0.01% 1359
2026
Q1 		$588K Buy
24,591
+3,820
+18% +$106K ﹤0.01% 1469
2025
Q4 		$576K Sell
20,771
-8,991
-30% -$229K ﹤0.01% 1482
2025
Q3 		$711K Buy
29,762
+1,602
+6% +$31.9K ﹤0.01% 1528
2025
Q2 		$480K Buy
28,160
+19,265
+217% +$335K ﹤0.01% 1615
2025
Q1 		$174K Buy
8,895
+362
+4% +$9.48K ﹤0.01% 1731
2024
Q4 		$212K Sell
8,533
-641
-7% -$16.4K ﹤0.01% 1740
2024
Q3 		$225K Buy
9,174
+344
+4% +$8.89K ﹤0.01% 1779
2024
Q2 		$207K Buy
8,830
+1,005
+13% +$24.7K ﹤0.01% 1808
2024
Q1 		$259K Buy
7,825
+396
+5% +$12.3K ﹤0.01% 1793
2023
Q4 		$200K Buy
7,429
+1,039
+16% +$25.8K ﹤0.01% 1842
2023
Q3 		$154K Buy
6,390
+3,000
+88% +$80.4K ﹤0.01% 1893
2023
Q2 		$109K Buy
3,390
+201
+6% +$6.52K ﹤0.01% 1915
2023
Q1 		$98K Sell
3,189
-245
-7% -$9.67K ﹤0.01% 1983
2022
Q4 		$136K Buy
3,434
+467
+16% +$20.9K ﹤0.01% 1932
2022
Q3 		$142K Buy
2,967
+74
+3% +$4.22K ﹤0.01% 1930
2022
Q2 		$112K Buy
2,893
+1,065
+58% +$42.3K ﹤0.01% 1899
2022
Q1 		$112K Buy
1,828
+66
+4% +$4.33K ﹤0.01% 1967
2021
Q4 		$140K Buy
1,762
+63
+4% +$5.39K ﹤0.01% 1938
2021
Q3 		$149K Hold
1,699
– – ﹤0.01% 1969
2021
Q2 		$218K Buy
1,699
+658
+63% +$52.4K ﹤0.01% 1909
2021
Q1 		$83K Sell
1,041
-365
-26% -$34.7K ﹤0.01% 2150
2020
Q4 		$114K Hold
1,406
– – ﹤0.01% 2084
2020
Q3 		$35K Hold
1,406
– – ﹤0.01% 2269
2020
Q2 		$39K Buy
+1,406
New +$30.3K ﹤0.01% 2300

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Canada Life's BEAM Position: Q2 2026 in Review

Canada Life increased its Beam Therapeutics (BEAM) stake by 22% in Q2 2026, buying an estimated $166K and bringing the position to 30,081 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1359.

Canada Life first reported a position in BEAM in Q2 2020 and has held it in 25 quarters since. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Canada Life held 30,081 shares of Beam Therapeutics worth $1.03M as of Q2 2026.
  • Canada Life bought 5,490 Beam Therapeutics shares in Q2 2026, an estimated $166K.
  • Beam Therapeutics made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1359 holding.
  • Canada Life first reported a position in Beam Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • 278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.